Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -460 | -2,047 | -1,559 | -1,035 | -1,405 |
| Depreciation Amortization | 64 | 384 | 279 | 172 | 81 |
| Accounts receivable | 1 | -21 | -15 | -15 | -9 |
| Accounts payable and accrued liabilities | -9 | 51 | -30 | -9 | 7 |
| Other Working Capital | 77 | 211 | 23 | -86 | -94 |
| Other Operating Activity | -1 | 258 | 359 | 280 | 1,015 |
| Operating Cash Flow | $-328 | $-1,164 | $-944 | $-693 | $-405 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -26 | -26 | -26 | -26 |
| Other Investing Activity | 0 | -25 | -25 | -25 | 0 |
| Investing Cash Flow | $N/A | $-51 | $-51 | $-51 | $-26 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 448 | 1,604 | 1,276 | 1,100 | 575 |
| Debt Repayment | -110 | -526 | -427 | -313 | -167 |
| Other Financing Activity | 0 | 113 | 113 | 0 | 0 |
| Financing Cash Flow | $338 | $1,191 | $962 | $787 | $409 |
| Beginning Cash Position | 12 | 36 | 36 | 36 | 36 |
| End Cash Position | 22 | 12 | 4 | 79 | 14 |
| Net Cash Flow | $10 | $-24 | $-33 | $43 | $-23 |
| Free Cash Flow | |||||
| Operating Cash Flow | -328 | -1,164 | -944 | -693 | -405 |
| Capital Expenditure | N/A | -26 | -26 | -26 | -26 |
| Free Cash Flow | -328 | -1,190 | -970 | -720 | -431 |